chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a medical assistant referring to an patient of unknown age and gender. The patients' pertinent medical history, drug reactions/allergies, concurrent conditions and concomitant medications were not reported. On an unknown date in 2017 (reported as: 06-APR-2017 to 08-NOV-2017), the patient was vaccinated with improperly stored dose of GARDASIL 9 (dose, frequency and route of administration were not reported) (lot # M035486, expiry date: 05-JUN-2019) for prophylaxis. The GARDASIL 9 was exposed to a total time in the range at or above 0 degrees C to 1 degrees C for 8.25 hours. It was reported the exact temperature and time below 0 degrees C was: -1.9 degrees C for 15 minutes, -1.2 degrees C for 15 minutes, -1.0 degrees C for 15 minutes, -0.8 degrees C for 15 minutes, -0.4 degrees C for 15 minutes and -0.2 degrees C for 1 hour 15 minutes. There was no previous temperature excursion. A "data logger" was involved. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter.
After my second dose of the vaccine I had typical flu-like symptoms (fever 101.5, chills/shivering, body pain, headache, nausea) yet also developed acute and severe shortness of breath. My flu-like symptoms resolved within 48 hours yet my breathing difficulties continued and worsened. I was treated in the Emergency Department on 1/12, 1/19 and 1/20 (work up negative for covid, pulmonary embolism, infection, cardiac abnormalities). It feels as though I am having intractable diaphragm spasms that are forcing my exhales out at the end of my breath cycle. I have lost 10lbs and have been essentially incapacitated for 6 weeks. I have been evaluated by head and neck (no vocal cord dysfunction), speech pathology (no swallowing difficulties), pulmonology (no lung specific issues) and am awaiting a neurology consult.
24 hrs after vaccination pt felt light headed, weak in her arms and legs, also dizzy. Symptoms lasted 4 days and resolved without treatment. dizziness kept her from normal activities.
Elevated temp - 2 hrs after vaccine administration w/nausea, vomiting, diarrhea, decreased appetite, decreased activity.
Was given the wrong dose (20 mg instead of 10 mcg) of the Pfizer vaccine
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 67-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 19Mar2021 at 11:45 as dose 1, single (Lot number: EP7534), in left arm, on 09Apr2021 at 11:45 as dose 2, single (Lot number: EW0151), in left arm and on 18Jan2022 at 11:15 as dose 3 (booster), single (Lot number: FK9729) at the age of 67 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "Penicillin allergy" (unspecified if ongoing); "Sulfa allergy" (unspecified if ongoing). Concomitant medication(s) included: PROGESTERONE, start date: Jun2019; ESTRADIOL [ESTRADIOL VALERATE], start date: Jun2019; BENADRYL; CETIRIZINE HCL. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "recovering" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: Antiviral drug details reported as Paxlovid (Lot Number: GD5273) taken for covid-19 treatment from 01Aug2022 to 06Aug2022.
Nausea; Swollen area; Redness; Welting/red welts; This case was reported by a pharmacist via call center representative and described the occurrence of nausea in a 67-year-old female patient who received Herpes zoster (Shingrix) (batch number 3L794, expiry date 21st September 2021) for prophylaxis.   On 28th June 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, less than a week after receiving Shingrix, the patient experienced nausea, injection site swelling, injection site erythema and injection site wheal. On an unknown date, the outcome of the nausea, injection site swelling, injection site erythema and injection site wheal were unknown.   It was unknown if the reporter considered the nausea, injection site swelling, injection site erythema and injection site wheal to be related to Shingrix.  Additional details were provided as follows: The pharmacist stated that the patient received Shingrix in the left deltoid and experienced nausea and swollen red welting area at the site of injection site. The patient came into the pharmacy at the time of reporting and the swollen red area has moved half way between the site of injection and above the elbow.
migraine Headache BP 235/110 was getting dizzy, tongue became numb she went to nurse   911 called. she was uncomfortable taking vaccination,  For 30 minutes she was ok- tongue numb lips swollen still has migraine TMJ pains Did not get epinephrine.  BP is on the "high normal side"  140/90, did not check pulse Oxygen level No rash
Upper right arm red, warm to touch. Area covers approximately 1/3 of upper outer aspect of arm. Child is scratching site. Parent reports low grade fever. Site is firm to touch, skin is taut. Denies pain at site.
Information has been received from a licensed practical nurse concerning a 11 year old female with allergy to cephalosporins who on 23-AUG-2010 was vaccinated with the first dose of GARDASIL (lot# 666595/0096Z, exp. 14-OCT-2012) 0.5 ml IM. There was no concomitant medication and lab data. The nurse was reporting the patient has experienced low-grade fever of 100.2F and headache since receiving her first dose of GARDASIL on 20-AUG-2010 (previously reported as 23-AUG-2010). The patient contacted the office by phone and was prescribed over-the-counter antipyretic medication. At the time of the report, the outcome of the patient was unknown. Follow up information has been received via from a healthcare professional medical records concerning an 11 year old female student with allergic reaction to CECLOR ; hives and anaphylaxis and allergy to ENDAL HD; hyperactivity; who on 23-AUG-2010, at 15:46 pm, was vaccinated with the first dose of GARDASIL intramuscularly in the left deltoid. There was no concomitant medication. On 22-AUG-2010 the patient experienced fever for a couple of days and headache for a couple of weeks. On 13-SEP-2010, the patient's sinus CT scan showed a complete opacification of the left maxillary sinus and the left osteomeatal complex is not visualized. Additional information is not expected.
crying intensely 2hr p/vax;1PM swelling size of 1/2dollar
I have runny nose after taking moderna vaccine; felt tired; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (I have runny nose after taking moderna vaccine) and FATIGUE (felt tired) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002821A) for COVID-19 vaccination.     Concomitant products included mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination, TORSEMIDE, MIRTAZAPINE, Tenatoprazole sobder, oxygen                                                         taken, TORSEMIDE, MIRTAZAPINE, Tenatoprazole sobder, LISINOPRIL, SPIRONOLACTONE, clopidogerel, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), vitamn D, isopsorbide mono ni ER, ATORVASTATIN, PARACETAMOL (TYLENOL), laxative                                                       every other day and Nitro                                                          for heart as needed for an unknown indication, LISINOPRIL.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2021, the patient experienced RHINORRHOEA (I have runny nose after taking moderna vaccine) and FATIGUE (felt tired). At the time of the report, RHINORRHOEA (I have runny nose after taking moderna vaccine) and FATIGUE (felt tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Low blood pressure; difficulty, generalized weakness for several days; chills; body aches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 76-year-old female patient received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series complete, Unknown Manufacturer), for COVID-19 immunization. The following information was reported: HYPOTENSION (non-serious), outcome "unknown", described as "Low blood pressure"; ASTHENIA (non-serious), outcome "unknown", described as "difficulty, generalized weakness for several days"; CHILLS (non-serious), outcome "unknown"; PAIN (non-serious), outcome "unknown", described as "body aches". Relevant laboratory tests and procedures are available in the appropriate section.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
swelling, redness, fever @ inj site, knot underarm, muscle soreness in underarm & lt back, stiffness in upper back & neck, lt back muscle pain unbearable;seen in ER & muscle relaxant given
Within 5 minutes of the patient receiving his vaccine he c/o of feeling dizzy, lightheaded and thought was going to pass out.  Patients vital signs were taken, given fluids, and ice pack, monitored for over 30 minutes. Patient remained conscious the entire event.  Initial BP dropped to 50/30's with hear rate in the 50's. Symptoms resolved, vital signs returned to baseline, patient denied further medical care and left the clinic without any further incidnece
Pt vaccinated with DTP/HIB/OPV 2 wks after vaccine administration developed generalized Morphea. Further exams pending.
Ongoing symptoms for the last 2 weeks. Primary exhaustion, a few days ago fever, chills.
pt recv vax 20JUN96 & 21JUN96 chills, upset stomach, redness;22JUN96 hive-like bumps on lt & rt hands;22JUN96 larger bumps on hands;23JUN96 blisters on both hands, chest pain;
COVID test result: Positive; COVID test result: Positive; hives; swelling of palms of hands; swelling of right eye; patches all over my body; Severe itching; starting to become severely allergic to chemicals and certain fruits and vegetable; starting to become severely allergic to chemicals and certain fruits and vegetable; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 10Sep2021 at 15:00 as dose 1, single (Lot number: F03184) at the age of 38 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Pistachios" (unspecified if ongoing); "Known allergies: peaches" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: PRURITUS (life threatening) with onset 12Sep2021, outcome "not recovered", described as "Severe itching"; URTICARIA (life threatening) with onset 12Sep2021, outcome "not recovered", described as "hives"; RASH (life threatening) with onset 12Sep2021, outcome "not recovered", described as "patches all over my body"; ALLERGY TO CHEMICALS (life threatening), FOOD ALLERGY (life threatening) all with onset 12Sep2021, outcome "not recovered" and all described as "starting to become severely allergic to chemicals and certain fruits and vegetable"; PERIPHERAL SWELLING (life threatening) with onset 12Sep2021, outcome "not recovered", described as "swelling of palms of hands"; EYE SWELLING (life threatening) with onset 12Sep2021, outcome "not recovered", described as "swelling of right eye"; DRUG INEFFECTIVE (medically significant, life threatening), COVID-19 (medically significant, life threatening) all with onset 03Jan2022, outcome "unknown" and all described as "COVID test result: Positive". The events "hives", "swelling of palms of hands", "swelling of right eye", "patches all over my body", "severe itching" and "starting to become severely allergic to chemicals and certain fruits and vegetable" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (03Jan2022) Positive. Therapeutic measures were taken as a result of urticaria, peripheral swelling, eye swelling, rash, pruritus, allergy to chemicals, food allergy. Clinical course: Patient did not had other vaccine in four weeks. Within 3 days of the 1st dose of vaccine she broke out in hives, swelling of palms of hands, right eye, patches all over her body. Severe itching. She was still battling these symptoms since 2 years. Got worse, started to become severely allergic to chemicals and certain fruits and vegetable that put her in the emergency room. The adverse event resulted in: [Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Life threatening illness (immediate risk of death from the event)]. Patient received the treatment with Citerizine, Benydryl, Epipen, Steroids. Patient did not had COVID prior vaccination. The COVID tested positive post vaccination.
pt recvd vax & devel fever w/ generalized sz; 1 1/2 hrs p/vax, resolved; no tx other than observation;
9/9/14 2:30A had generalized seizure with clonic movements of all extremities. Pt taken to ER by ambulance.
3.5 x 6.5 red oval lesion with an area protruding to 7 cm on left upper thigh. Not tender to palpation.
severe neck pain leading to injection site; injection site pain; some shoulder pain; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (severe neck pain leading to injection site), INJECTION SITE PAIN (injection site pain) and ARTHRALGIA (some shoulder pain) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced NECK PAIN (severe neck pain leading to injection site), INJECTION SITE PAIN (injection site pain) and ARTHRALGIA (some shoulder pain). On 11-Mar-2021, INJECTION SITE PAIN (injection site pain) had resolved. At the time of the report, NECK PAIN (severe neck pain leading to injection site) and ARTHRALGIA (some shoulder pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication details were not provided. No treatment information was provided.
Confusion; Swollen face; Swollen lips; Swollen ankles; Swollen right arm; Fever 100.0 F for a few days.; Memory loss for few days; Disorientation; Difficulty walking; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: TW0151) via an unspecified route of administration in the left arm on 07Apr2021 at 10:30 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included kidney transplant, lupus, rheumatoid arthritis and vasculitis; all from unknown dates. The patient had known allergies to sulfa and ciprofloxacin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included acetylsalicylic acid (ASPIRIN), prednisone (MANUFACTURER UNKNOWN) and unspecified heart medications and immunosuppressive; all from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 08:15, the patient experienced confusion, swollen face and lips, swollen ankles and right arm, fever 100.0 F (Fahrenheit) for a few days, memory loss for a few days, disorientation and difficulty walking. On 09Apr2021, the patient's body temperature was found to be 100.0 F. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events confusion, swollen face and lips, swollen ankles and right arm, fever 100.0 F for few days, memory loss for few days, disorientation and difficulty walking was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
I started getting welts and hives on different parts of the body, my neck, stomach, back, legs, arms, everywhere. I took some Benadryl and it didn't go away. I reached out to the doctor on 02/01/2021 and he gave me a dose pack and a cortisone shot. The hives went away for a few weeks and came back. I went to the dermatologist on 03/17/2021, had a biopsy and prescribed a cream. On 5/7/2021, I went back to the doctor because my upper lip was swollen and I had hives again. I was given another cortisone shot and they went away for a few weeks and came back. On 5/26/2021, I had a televisit with my Allergist and was told to up the dosage of my Allegra and was prescribe Pepcid. On 6/01/2021, it happened again with bright red hives with funny shapes all over my legs. I went back to the doctor and was given another cortisone shot and was referred to a new dermatologist.
Started at 3:00 am on 01/01/2021 with fever, chills, and vomiting. Vomiting has continued through 01/03/2021. He started vomiting blood on 01/03/2021.
PT REPORTS RECEIVING PFIZER COVID VACCINE AT UNKNOWN PROVIDER ON 02/22/2021, 03/11/2021 AND 10/11/2021.  REPORTED BEING ADMITTED TO A LOCAL HOSPITAL 10/15/2021 FOR PULONARY EMBOLISM.  DISCHARGED ON XARELTO.  CAME TO DR.  12/10/2021 FOR FOLLOW UP AFTER HOSPITAL DISCHARGE AND REPORTED THIS AS POSSIBLE ADVERSE REACTION TO THE COVID VACCINE.
48 hours - lymph node swelling; 48 hours - lymph node swelling and pain in armpit area (left side) same side as injection site. Currently swelling still present and slight pain; chills; fatigue; booster; This is a spontaneous report received from a contactable reporter (Consumer or other non-HCP). The reporter is the patient.  A 56-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 30Nov2021 10:00 (Lot number: 33030BD) at the age of 56 years as dose 3 (booster), single for covid-19 immunization. The patient's relevant medical history was not reported. Concomitant medication(s) included ATORVASTATIN; VITAMIN D 2000. Vaccination history included Bnt162b2 (Dose Number: 1, Batch/Lot No: EN6203, Location of injection: Arm Left, Vaccine Administration Time: 02:15 PM), administration date: 27Feb2021, when the patient was 56 years old, for COVID-19 immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: ER8727, Location of injection: Arm Left, Vaccine Administration Time: 01:15 PM), administration date: 21Mar2021, when the patient was 56 years old, for COVID-19 immunization, reaction(s) chills; Bnt162b2 (2nd dose), when the patient was 56 years old, for COVID-19 immunization, reaction(s) fatigue. The following information was reported IMMUNISATION (non-serious) with onset 30Nov2021 10:00, outcome unknown; LYMPHADENOPATHY (non-serious) with onset 02Dec2021 09:00, outcome recovering; LYMPH NODE PAIN (non-serious) with onset 02Dec2021 09:00, outcome recovering. Currently swelling still present and slight pain; CHILLS (non-serious) with onset 02Dec2021 09:00, outcome recovering; FATIGUE (non-serious) with onset 02Dec2021 09:00, outcome recovering. Therapeutic measures were not taken as a result of lymphadenopathy, lymph node pain, chills, fatigue.  The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was neither diagnosed with COVID-19 Prior to vaccination nor been tested for COVID-19 since the vaccination. 48 hours - lymph node swelling and pain in armpit area (left side) same side as injection site. Currently, swelling still present and slight pain. The lymph node adverse event was new, after her 2nd dose & 3rd dose, the patient had chills, and fatigue that lasted less than 24 hours.   No follow-up attempts are possible. No further information is expected.
Patient had night terrors and looked like convulsions while rolling her eyes back. I didn't know what to do. I held her till it stopped. It started around 11pm off and on and stopped after 2am on February 21st and 22nd. She is better now, but very fussy.
local reaction; This spontaneous case was reported by an other health care professional and describes the occurrence of LOCAL REACTION (local reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced LOCAL REACTION (local reaction). At the time of the report, LOCAL REACTION (local reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator No treatment medications provided by the reporter.; Sender's Comments: Very limited information regarding this event has been provided at this time. Further information has been  requested.
Vaccine administered on 10/24/14. Approx 12 hours later unable to move neck or lift feel left arm. Pain ongoing since vaccine. Seen by neurologist, pain management, ortho.
Patient reports trouble breathing, dizziness and lower back pain. Patient bp checked, O2 checked and visually monitored. After aprox 10 mins Patient has was asymptomatic